{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hewitt SC"],"funding":["Intramural NIH HHS","PHS HHS"],"pagination":["344-52"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4383572"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["123(4)"],"pubmed_abstract":["<h4>Background</h4>Concerns regarding potential endocrine-disrupting chemicals (EDCs) have led to a need for methods to evaluate candidate estrogenic chemicals. Our previous evaluations of two such EDCs revealed a response similar to that of estradiol (E2) at 2 hr, but a less robust response at 24 hr, similar to the short-acting estrogen estriol (E3).<h4>Objectives</h4>Microarray analysis using tools to recognize patterns of response have been utilized in the cancer field to develop biomarker panels of transcripts for diagnosis and selection of treatments most likely to be effective. Biological effects elicited by long- versus short-acting estrogens greatly affect the risks associated with exposures; therefore, we sought to develop tools to predict the ability of chemicals to maintain estr"],"journal":["Environmental health perspectives"],"pubmed_title":["Development of phenotypic and transcriptional biomarkers to evaluate relative activity of potentially estrogenic chemicals in ovariectomized mice."],"pmcid":["PMC4383572"],"funding_grant_id":["IRP Z0170065"],"pubmed_authors":["Winuthayanon W","Bushel PR","Hewitt SC","Pockette B","Kerns RT","Foley JF","Flagler N","Ney E","Suksamrarn A","Korach KS","Piyachaturawat P"],"additional_accession":[]},"is_claimable":false,"name":"Development of phenotypic and transcriptional biomarkers to evaluate relative activity of potentially estrogenic chemicals in ovariectomized mice.","description":"<h4>Background</h4>Concerns regarding potential endocrine-disrupting chemicals (EDCs) have led to a need for methods to evaluate candidate estrogenic chemicals. Our previous evaluations of two such EDCs revealed a response similar to that of estradiol (E2) at 2 hr, but a less robust response at 24 hr, similar to the short-acting estrogen estriol (E3).<h4>Objectives</h4>Microarray analysis using tools to recognize patterns of response have been utilized in the cancer field to develop biomarker panels of transcripts for diagnosis and selection of treatments most likely to be effective. Biological effects elicited by long- versus short-acting estrogens greatly affect the risks associated with exposures; therefore, we sought to develop tools to predict the ability of chemicals to maintain estr","dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Apr","modification":"2026-05-01T18:01:04.748Z","creation":"2026-04-07T17:10:09.461Z"},"accession":"S-EPMC4383572","cross_references":{"pubmed":["25575267"],"doi":["10.1289/ehp.1307935"]}}